TRPV1 variants impair intracellular Ca2+ signaling and may confer susceptibility to malignant hyperthermia.
TRPV1 variants impair intracellular Ca2+ signaling and may confer susceptibility to malignant hyperthermia. Genet Med. 2019 02; 21(2):441-450.